(0.02%) 5 207.50 points
(0.03%) 39 010 points
(-0.06%) 18 185 points
(0.18%) $78.62
(-1.37%) $2.17
(-0.01%) $2 331.00
(-0.20%) $27.56
(0.77%) $972.35
(0.07%) $0.929
(0.30%) $10.86
(0.09%) $0.797
(0.03%) $91.37
2 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 0.00%
1.23% ¥ 2 217.00
Live Chart Being Loaded With Signals
FALCO HOLDINGS Co., Ltd., a medical service company, primarily provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan...
Stats | |
---|---|
Volumen de hoy | 7 800.00 |
Volumen promedio | 26 598.00 |
Capitalización de mercado | 23.47B |
EPS | ¥0 ( 2024-02-08 ) |
Próxima fecha de ganancias | ( ¥0 ) 2024-05-09 |
Last Dividend | ¥36.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 12.15 |
ATR14 | ¥5.53 (0.25%) |
FALCO HOLDINGS Co., Ltd. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
FALCO HOLDINGS Co., Ltd. Finanzas
Annual | 2022 |
Ingresos: | ¥46.91B |
Beneficio Bruto: | ¥14.64B (31.22 %) |
EPS: | ¥215.22 |
FY | 2022 |
Ingresos: | ¥46.91B |
Beneficio Bruto: | ¥14.64B (31.22 %) |
EPS: | ¥215.22 |
FY | 2022 |
Ingresos: | ¥50.01B |
Beneficio Bruto: | ¥17.32B (34.64 %) |
EPS: | ¥339.00 |
FY | 2021 |
Ingresos: | ¥43.61B |
Beneficio Bruto: | ¥13.70B (31.41 %) |
EPS: | ¥178.61 |
Financial Reports:
No articles found.
FALCO HOLDINGS Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥32.00 (N/A) |
¥0 (N/A) |
¥36.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥2.00 | 2005-03-15 |
Last Dividend | ¥36.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 31 | -- |
Total Paid Out | ¥472.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.35 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.34 | |
Div. Directional Score | 6.80 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8218.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7599.T | Ex Dividend Knight | 2024-02-28 | Semi-Annually | 0 | 0.00% | |
6794.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6138.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
4845.T | Ex Dividend Junior | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
4047.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3276.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
2301.T | Ex Dividend Knight | 2023-10-30 | Semi-Annually | 0 | 0.00% | |
9790.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
8877.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0460 | 1.500 | 9.08 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0541 | 1.200 | 8.20 | 9.83 | [0 - 0.3] |
returnOnEquityTTM | 0.0765 | 1.500 | -0.261 | -0.391 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.30 | 0.800 | 3.49 | 2.79 | [1 - 3] |
quickRatioTTM | 1.892 | 0.800 | 3.58 | 2.86 | [0.8 - 2.5] |
cashRatioTTM | 1.171 | 1.500 | 4.61 | 6.91 | [0.2 - 2] |
debtRatioTTM | 0.0136 | -1.500 | 9.77 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 182.64 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 184.51 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 184.51 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0194 | -1.500 | 9.92 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.301 | 1.000 | 8.32 | 8.32 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0463 | 1.000 | -1.073 | -1.073 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 4.02 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 1.176 | 0.800 | 5.49 | 4.40 | [0.5 - 2] |
Total Score | 10.26 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 11.95 | 1.000 | 8.89 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0765 | 2.50 | -0.168 | -0.391 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 184.51 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.42 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 184.51 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.127 | 1.500 | -2.49 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0464 | 1.000 | -1.341 | 0 | [0.1 - 0.5] |
Total Score | 3.34 |
FALCO HOLDINGS Co., Ltd.
FALCO HOLDINGS Co., Ltd., a medical service company, primarily provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan. It offers clinical testing services in the fields of genetic tests, biochemistry, hematology, pathology, immunology, microbiology, and radio immunoassay; genetic testing services; and genomic-based drug discovery and biotechnology drug development services. The company also provides medical information technology services; food sanitation and environmental testing services; and food related genetic testing services to food manufacturers, retailers, and restaurants. In addition, it is involved in the dispensing pharmacies and drugstores business; and development and sale of various medical information systems, including @home Dr. electronic medical charts for clinics with concentrated clinical testing, as well as TASCAL for ASP, a medical support system. The company was founded in 1962 and is headquartered in Kyoto, Japan.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico